Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients
- PMID: 17287462
- PMCID: PMC2995532
- DOI: 10.2337/db06-0783
Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients
Abstract
Insulin resistance is the best predictor for the development of diabetes in offspring of type 2 diabetic patients, but the mechanism responsible for it remains unknown. Recent studies have demonstrated increased intramyocellular lipid, decreased mitochondrial ATP synthesis, and decreased mitochondrial density in the muscle of lean, insulin-resistant offspring of type 2 diabetic patients. These data suggest an important role for mitochondrial dysfunction in the pathogenesis of type 2 diabetes. To further explore this hypothesis, we assessed rates of substrate oxidation in the muscle of these same individuals using (13)C magnetic resonance spectroscopy (MRS). Young, lean, insulin-resistant offspring of type 2 diabetic patients and insulin-sensitive control subjects underwent (13)C MRS studies to noninvasively assess rates of substrate oxidation in muscle by monitoring the incorporation of (13)C label into C(4) glutamate during a [2-(13)C]acetate infusion. Using this approach, we found that rates of muscle mitochondrial substrate oxidation were decreased by 30% in lean, insulin-resistant offspring (59.8 +/- 5.1 nmol x g(-1) x min(-1), P = 0.02) compared with insulin-sensitive control subjects (96.1 +/- 16.3 nmol x g(-1) x min(-1)). These data support the hypothesis that insulin resistance in skeletal muscle of insulin-resistant offspring is associated with dysregulation of intramyocellular fatty acid metabolism, possibly because of an inherited defect in the activity of mitochondrial oxidative phosphorylation.
Figures




Similar articles
-
Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.PLoS Med. 2005 Sep;2(9):e233. doi: 10.1371/journal.pmed.0020233. Epub 2005 Aug 16. PLoS Med. 2005. PMID: 16089501 Free PMC article. Clinical Trial.
-
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.N Engl J Med. 2004 Feb 12;350(7):664-71. doi: 10.1056/NEJMoa031314. N Engl J Med. 2004. PMID: 14960743 Free PMC article.
-
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.J Clin Invest. 2005 Dec;115(12):3587-93. doi: 10.1172/JCI25151. Epub 2005 Nov 10. J Clin Invest. 2005. PMID: 16284649 Free PMC article.
-
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.Diabetes. 2006 Dec;55 Suppl 2(Suppl 2):S9-S15. doi: 10.2337/db06-S002. Diabetes. 2006. PMID: 17130651 Free PMC article. Review.
-
Mitochondrial oxidative function and type 2 diabetes.Appl Physiol Nutr Metab. 2006 Dec;31(6):675-83. doi: 10.1139/h06-071. Appl Physiol Nutr Metab. 2006. PMID: 17213881 Review.
Cited by
-
Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation.Diabetes. 2013 Oct;62(10):3404-17. doi: 10.2337/db12-1650. Epub 2013 Jul 8. Diabetes. 2013. PMID: 23835326 Free PMC article.
-
Use of dicarboxylic acids in type 2 diabetes.Br J Clin Pharmacol. 2013 Mar;75(3):671-6. doi: 10.1111/j.1365-2125.2012.04177.x. Br J Clin Pharmacol. 2013. PMID: 22242741 Free PMC article. Review.
-
Development of insulin resistance in mice lacking PGC-1α in adipose tissues.Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9635-40. doi: 10.1073/pnas.1207287109. Epub 2012 May 29. Proc Natl Acad Sci U S A. 2012. PMID: 22645355 Free PMC article.
-
Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues.Cell Rep Med. 2022 Oct 18;3(10):100763. doi: 10.1016/j.xcrm.2022.100763. Epub 2022 Oct 4. Cell Rep Med. 2022. PMID: 36198307 Free PMC article.
-
Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.PLoS One. 2010 Jun 4;5(6):e10956. doi: 10.1371/journal.pone.0010956. PLoS One. 2010. PMID: 20532041 Free PMC article.
References
-
- Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990;113:909–915. - PubMed
-
- Phillips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in non-diabetic subjects. Metabolism. 1996;45:947–950. - PubMed
-
- Krssak M, Petersen KF, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999;42:113–116. - PubMed
-
- Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab. 1999;276:E977–E989. - PubMed
-
- Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcellono C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 1999;48:1600–1606. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous